Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy: A prospective, multicentre cohort study. The lancet oncology, June 2013, Vol. 14(7), p.609-18
Kuehn, T., et al.
http://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(13)70166-9/abstract?rss=yes
The optimum timing of sentinel-lymph-node biopsy for breast cancer patients treated with neoadjuvant chemotherapy is uncertain. The SENTINA (SENTinel NeoAdjuvant) study was designed to evaluate a specific algorithm for timing of a standardised sentinel-lymph-node biopsy procedure in patients who undergo neoadjuvant chemotherapy.
